From: Proton beam therapy for hepatocellular carcinoma with bile duct invasion
Author | Year | N | BDTT | Treatment | OS |
---|---|---|---|---|---|
Ikenaga, et al [1] | 2009 | 15 | NR | Surgery | 1-yr 46%, 3-yr 23%, 5-yr 0% |
Zeng, et al. [17] | 2015 | 37 | 100% | Surgery | 1-yr 64.2%, 2-yr 38.9%, 3-yr 24.3% |
Jang, et al [18] | 2015 | 13 | NR | Surgery | 1-yr 69.2%, 2-yr 53.8%, 3-yr 46.2% |
Yang, et al [5] | 2018 | 107 | NR | Surgery | 1-yr 60.5%, 3-yr 20.1%, 5-yr 12.0% |
Current Study | Â | 15 | 86.7% | PBT | 1-yr 80.0%, 2-yr 58.7%, 3-yr 40.2% |